Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Post by Sextanton Dec 31, 2020 8:20pm
361 Views
Post# 32206278

Vested interest=shareholder alignment

Vested interest=shareholder alignmentThe following four individuals hold a lot of paper in Hemostemix.
I invite you to dig a little and ascertain the level of insider ownership.
I have come to really appreciate guys with skin in the game.
Good luck and best wishes for a healthy and WEALTHY 2021.

Sextant


Peter Lacey, ICD.D, Chairman of the Board

  • Chairman of Cervus Equipment Corporation (CERV.TO), from inception to date.
  • President and Chief Executive Officer of Cervus Equipment Corporation and its predecessor entities from 1982 to April 2012.
  • Cervus is a  he and his partners started in 1999 and built from five John Deere dealerships to 63 dealerships selling six brands in three countries with revenues of $1.1 Billion
  • Graduate of the Institute of Corporate Directors Education Program at the University of Toronto.

Dr. Ronnie Hershman, M.D., F.C.C.S. , Director

  • Graduated Magna   from Sophie Davis Center for Biomedical Research in 1980.
  • Practicing Cardiologist since 1987 and Medical Director of NYU Langone Long island Cardiac Care.
  • Pioneer in performing laser assisted coronary angioplasty
  • Entrepreneur and investor for more than two decades and director and/or officer of over 9 life science companies.
  • Track record of investing in companies that commercialize technologies quickly and globally
  • Advisor to late stage life science VC that has funded 24 companies

Thomas Smeenk, BA, Director 

  • Founder, President and VP Business Development, TheraVitae Inc., which went public as Hemostemix Inc. QT.
  • A finance and business development executive with a proven track record of bringing new discoveries to market.
  • A public company executive since 1996, serving most recently as President & CEO of Broadway Gold Mining Ltd, where he completed a $30  million agreement with Rio Tinto. Prior, VP Business Development, Memex Inc. (TSXV:MEM); President & CEO of e-Manufacturing Networks Inc. (TSXV:OEE); President and CEO of Tyranex Gold Inc. and President and CEO of IBI Corporation

Loran Swanberg, Director

  • Part owner and a director of a private company, Landsman Properties Ltd. since 2005. Landsman owns and leases out shop and office space in North East British Columbia and Alberta.
  • From 1992 to 2005, Mr. Swanberg was a director of the family owned oilfield transportation company, Swanberg Bros. Trucking Ltd., which was purchased by Producers Oilfield Services Inc. in 2005.
  • Director of privately held Swanberg Air Inc. from 2000 to 2012, and was a director of the Northern B.C. Truckers’ Association for 10 years, 1992 to 2002.
  • Most recently, Mr. Swanberg was a partner and director of Vieworx Geophoto Inc. from 2012 until Q1 2020.

<< Previous
Bullboard Posts
Next >>